These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28303695)

  • 1. Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.
    Hatzoglou V; Tisnado J; Mehta A; Peck KK; Daras M; Omuro AM; Beal K; Holodny AI
    Cancer Med; 2017 Apr; 6(4):761-767. PubMed ID: 28303695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
    Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
    J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
    Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
    Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram Analysis of ADC Maps for Differentiating Brain Metastases From Different Histological Types of Lung Cancers.
    Bozdağ M; Er A; Çinkooğlu A
    Can Assoc Radiol J; 2021 May; 72(2):271-278. PubMed ID: 32602365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.
    Jung BC; Arevalo-Perez J; Lyo JK; Holodny AI; Karimi S; Young RJ; Peck KK
    J Neuroimaging; 2016; 26(2):240-6. PubMed ID: 26235208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.
    Lee SH; Rimner A; Gelb E; Deasy JO; Hunt MA; Humm JL; Tyagi N
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):718-726. PubMed ID: 29680254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps.
    Müller SJ; Khadhraoui E; Neef NE; Riedel CH; Ernst M
    BMC Med Imaging; 2021 Apr; 21(1):70. PubMed ID: 33858368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
    Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
    Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
    Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
    Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.
    Lee SH; Rimner A; Deasy JO; Hunt MA; Tyagi N
    J Appl Clin Med Phys; 2019 Nov; 20(11):169-188. PubMed ID: 31602789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.
    Guan Y; Peck KK; Lyo J; Tisnado J; Lis E; Arevalo-Perez J; Yamada Y; Hameed MR; Karimi S; Holodny A
    Radiology; 2020 Nov; 297(2):382-389. PubMed ID: 32870135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
    Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
    Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Brain Metastases Based on MRI Using Efficientnet and Transfer Learning Approach.
    Grossman R; Haim O; Abramov S; Shofty B; Artzi M
    Technol Cancer Res Treat; 2021; 20():15330338211004919. PubMed ID: 34030542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study.
    Ortiz-Ramón R; Larroza A; Ruiz-España S; Arana E; Moratal D
    Eur Radiol; 2018 Nov; 28(11):4514-4523. PubMed ID: 29761357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.
    Saha A; Peck KK; Lis E; Holodny AI; Yamada Y; Karimi S
    Spine (Phila Pa 1976); 2014 Nov; 39(24):E1433-40. PubMed ID: 25188594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
    Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
    J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
    Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
    Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
    Hatzoglou V; Yang TJ; Omuro A; Gavrilovic I; Ulaner G; Rubel J; Schneider T; Woo KM; Zhang Z; Peck KK; Beal K; Young RJ
    Neuro Oncol; 2016 Jun; 18(6):873-80. PubMed ID: 26688076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.